Interleukin 1 is the prototype of an inflammatory cytokine, and evidence suggests that it uses the sphingomyelin pathway and ceramide production to trigger mitogen-activated protein kinase (MAPK) activation and subsequent gene expression required for acute inflammatory processes. To identify downstream signaling targets of ceramide, a radioiodinated photoaffinity labeling analog of ceramide ([1251]3-trifluoromethyl-3-(m-iodophenyl)diazirineceramide) was employed. It is observed that ceramide specifically binds to and activates protein kinase c-Raf, leading to a subsequent activation of the MAPK cascade. Ceramide does not bind to any other member of the MAPK module nor does it bind to protein kinase C-c. These data identify protein kinase c-Raf as a specific molecular target for interleukin 1,8-stimulated ceramide formation and demonstrate that ceramide is a lipid cofactor participating in regulation of c-Raf activity.
Interleukin 1 (IL-1) is a major product of activated monocytes and is also released by many cell types when exposed to an inflammatory environment. The biological activities of IL-1 are initiated by binding to two types of IL-1 receptors, designated IL-1 receptors type I and type II. Although the cytoplasmic portions of both IL-1 receptors do not contain kinase domains or motifs homologous to any other known signaling pathway, rapid intracellular protein phosphorylation occurs in response to IL-1 stimulation. The nature of the primary signal delivered by IL-1 receptor activation is poorly understood and controversial (1) , but it is clear that IL-1 does stimulate protein kinase activities in a wide variety of different cell types. IL-1 and tumor necrosis factor a have been shown to induce rapid mitogen-activated protein kinase (MAPK) activation in fibroblasts, U937 cells, KB cells, and mesangial cells (2) (3) (4) (5) (6) . Furthermore, both cytokines employ the sphingomyelin signaling pathway to generate ceramide and to stimulate a putative ceramide-activated serine/threonine protein kinase (7) (8) (9) . Lipid second messengers are increasingly recognized as important mediators of extracellular signals, and ceramide generated by the action of neutral and acidic sphingomyelinases has been implicated in a variety of physiological processes, like effects on cell growth, differentiation, and apoptosis (8, 9) .
Rat renal mesangial cells are a well-defined IL-i-responsive cell type that is involved in most pathological processes of the renal glomerulus (10, 11) . Resting mesangial cells do not produce any inflammatory mediator constitutively but require a triggering by invading immune cells. Three prominent features of mesangial cells evolve as a result of the crosstalk with invading neutrophils and macrophages, as follows: increased mediator production, increased matrix synthesis, and increased mesangial cell proliferation (10, 11) . IL-1 has been reported to induce the expression of a specific type IV collagenase, a group II phospholipase A2, eicosanoids, an inducible nitric oxide synthase, and a variety of chemokines in mesangial cells (11) . We have used rat mesangial cells as a model system to evaluate IL-1-induced signaling events and report that IL-1 stimulates ceramide production, which subsequently specifically binds to and activates protein kinase c-Raf.
MATERIALS AND METHODS
Cell Culture. Rat renal mesangial cells were cultured as described (12 ITo whom reprint requests should be addressed.
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Samples (1 ml), containing 150 x 106 cpm of labeled proteins, 5% fetal calf serum, and 1.5 mM iodoacetamide in buffer A were incubated with the indicated antibodies for 3 h at room temperature, or overnight at 4°C. Then 100 ,l of a 50% (vol/vol) slurry of protein A-Sepharose 4B-CL in PBS was added, and the mixture was incubated for 1 h under mild shaking. After centrifugation for 5 min at 3000 x g, immunocomplexes were washed three times with 1 ml of a low-salt buffer (50 mM Tris HCl, pH 7.5/150 mM NaCl/0.2% Triton X-100/2 mM EDTA/2 mM EGTA/0.1% SDS) and three times with a high-salt buffer (50 mM Tris HCl, pH 7.5/500 mM NaCl/0.2% Triton X-100/2 mM EDTA/2 mM EGTA/0.1% SDS). Pellets wer boiled for S min in 50 gl of Laemmli dissociation buffer and subjected to SDS/PAGE.
3-Trifluoromethyl-3-(m-iodophenyl)diazirine (TID) Labeling Studies. Confluent mesangial cells were incubated for 2 days in DMEM containing 0.1 mg of fatty acid-free BSA per ml. Thereafter cells were stimulated for 5 min with 50 nM
TID-ceramide; 0.2 mCi/ml) and subjected to photolysis for 30 s using a high-pressure mercury lamp (Osram HBO, 350 W; Osram, Berlin, Germany) mounted in a SUSS LH 1000 lamphouse equipped with a shutter to control exposure time. Cells were then lysed in buffer A homogenized by 10 passes through a 26-gauge needle fitted to a 1-ml syringe and centrifuged for 10 min at 14,000 x g, and the supernatant was taken for immunoprecipitation and subjected to SDS/PAGE.
The antibodies for c-Raf, p42 and p44 isoforms of MAPK, MAPK kinase (MEK), and protein kinase C (PKC)-; have been characterized in detail elsewhere (14) (15) (16) . After fixation in 25% isopropanol/10% acetic acid, the gels were dried and exposed to Hyperfilm MP (Amersham) at -70°C.
MAPK Activity Assay. MAPK activity assays were performed as described (15) . In brief, stimulated cells were lysed and homogenized in kinase buffer (20 mM Tris HCl, pH 7.5/1 mM EGTA/2 mM MnCl2/0.1 mM sodium orthovanadate/25 ,tg of leupeptin per ml/200 units of aprotinin per ml/1 ,uM pepstatin A/1 mM phenylmethylsulfonyl fluoride) by 10 passes through a 26-gauge needle, centrifuged for 5 min at 14,000 x g, and the supernatant was taken for determination of protein concentration. Cell extracts (50 ,tg) were incubated for 15 min at 30°C in the presence of 20 pLg of myelin basic protein, 10 ,uM ATP, and 2 ,uCi of [y-32P]ATP. The reaction was terminated by adding Laemmli buffer, and samples were subjected to SDS/PAGE (14% acrylamide gel) followed by autoradiography to visualize the phosphorylation of myelin basic protein.
c-Raf Activity Assay. Stimulated cells were lysed in buffer A and homogenized by 10 passes through a 26-gauge needle. Homogenates were centrifuged for 10 min at 14,000 x g, and the supernatant was taken for immunoprecipitation of c-Raf using a C terminus-specific polyclonal antibody as described (14) . Immunoprecipitates were incubated for 10 min at 37°C in a 50-gl kinase reaction containing 10 mM Tris HCl (pH 7.5), 10 mM MnCl2, 150 mM NaCl, 2 mM dithiothreitol, 1% Triton 
RESULTS
Upon exposure to IL-1fB, mesangial cells hydrolyze sphingomyelin to generate ceramide (Table 1) and display a rapid activation of MAPK, which is sustained for >24 h (5). To identify possible molecular targets of ceramide signaling in mesangial cells, we prepared a photoaffinity labeling analog of ceramide of high [12 I]iodine-specific radioactivity (>2000 Ci/mmol) (17) labeling of protein kinase c-Raf (Fig. 1A) , which is increased up to 243 ± 37% (mean + SD, n = 4) upon UV-induced labeling. There is no labeling of the p42 and p44 isoforms of MAPK nor of their upstream activator MEK, MEK kinase, PKC-C, or any protein immunoprecipitated with an antiphosphotyrosine antibody (PY) as shown in Fig. 1A . All antibodies used in this study have been shown to immunoprecipitate their respective antigens (14) (15) (16) . Labeling by [1251]TID-ceramide is inhibited by exogenous addition of increasing concentrations of unlabeled ceramide (Fig. 1B) as well as by endogenous ceramide produced by IL-113 prestimulation of the cells (Fig. IB) . These data establish that IL-1,8-induced ceramide specifically binds to c-Raf in mesangial cells. Comparable data were obtained for tumor necrosis factor a-stimulated mesangial cells (data not shown).
Next we investigated whether ceramide binding to c-Raf also has functional consequences. Fig. 2A shows that C6 and C16 analogs of ceramide, in a concentration-dependent manner, increase protein kinase c-Raf activity in an immunocomplex kinase assay in vitro. Moreover, C6 and C16 analogs also activate protein kinase c-Raf in vivo when added to intact cells and subsequent evaluation of c-Raf activity by an immunocomplex kinase assay (Fig. 2B) . Fig. 2C demonstrates that ceramide analogs not only activate c-Raf but that the signal is further processed along the MAPK cascade and causes an increased activity of the p42 and p44 isoforms of MAPK. Ceramide-stimulated activation of MAPK is inhibited by PD 098059 (18), a synthetic inhibitor of MEK (data not shown). To prove that IL-1l3 indeed uses this signaling pathway to activate c-Raf in mesangial cells, we examined c-Raf phosphorylation and activity. As shown in Fig. 3, IL-1 
DISCUSSION
The serine/threonine kinase c-Raf is a well-studied signaling molecule that is responsible for phosphorylation and activation of MEK in the classical MAPK cascade (19) . The mechanism of activation of protein kinase c-Raf has been studied extensively, and it is now clear that.this is a multistep event. In a first step, c-Raf translocates to the plasma membrane and associates with Ras-GTP. However, this association with Ras-GTP is not sufficient for c-Raf activation but is required for its recruitment to the plasma membrane (20, 21) . In a second step, c-Raf is activated by an unknown mechanism that may comprise tyrosine and/or serine/threonine phosphorylation of c-Raf (14, 19, (22) (23) (24) (25) or the interaction with another membrane cofactor such as a lipid (18, 24, 25) . The c-Raf amino terminus contains a highly. conserved region (CR-1) that encompasses a zinc-finger motif analogous to the lipid-binding domain of PKC (19) , and it is tempting to speculate that c-Raf is activated by binding of a lipid second messenger in away similar to the mechanism of activation of PKC by 1,2-diacylglycerol.
The present data clearly demonstrate that ceramide specifically binds to c-Raf and stimulates its kinase activity. These observations extend previous reports on putative lipid factors extractable with chloroform/methanol from membranes of activated cells that markedly enhance c-Raf enzymatic activity (19, 25) and identify ceramide as a lipid second messenger that acts as a major direct activator of c-Raf in IL-1l3-triggered signal propagation. Ceramide has gained recognition as an important signaling molecule regulating fundamental biological processes, like cell proliferation and differentiation, oncogenesis, and immune and inflammatory processes (8, 9) . Ceramide is produced by sphingomyelin hydrolysis by both neutral and acid sphingomyelinases. With respect to immediate targets of ceramide, suggestions for several ceramideactivated enzymes have been forwarded. These include a 97-kDa proline-directed serine/threonine protein kinase (26, 27) , a ceramide-activated protein phosphatase (28) and PKC-G (29) . Recently Yao et al. (30) observed that a 97-kDa ceramide-activated protein kinase phosphorylates c-Raf on Thr-269 and increases its activity toward MEK. Furthermore, in intact HL-60 cells, ceramide-activated protein kinase forms complexes with c-Raf and, in response to tumor necrosis factor a, phosphorylates and activates c-Raf. In IL-1,3-stimulated mesangial cells, ceramide definitely does not bind to PKC-C and there is also no ceramide-binding protein in the range of 97 kDa visible in the cell homogenates (data not shown). In contrast, our data define c-Raf as a ceramide-activated protein kinase, thus suggesting that there is more than one ceramideactivated protein kinase and that ceramide may have cell-type specific targets.
Previous reports suggested that short-chain ceramide analogs are biologically more active than their long-chain equivalents likely due to the increased solubility of the former. Based on this background, the observation that the C16-ceramides were more potent the C6-ceramides in activating c-Raf is rather unexpected. Moreover, we observed that stimulation of c-Raf activity in vivo occurs at lower concentrations of both ceramide derivatives than in vitro.
A possible explanation could be that C16-ceramide was a natural product, whereas C6-ceramide was a synthetic compound. In addition to chain length and solubility in aqueous solution, other factors may be important for biological activity, especially the degree of unsaturation of the alkyl chains. (1996) " I nase c-Raf by ceramide is probably only one possible way to activate this kinase, especially in response to cytokines like IL-1f3 or tumor necrosis factor a. Activation of c-Raf by phosphorylation is an alternative mechanism used by tyrosine kinase receptor agonists or G-protein-coupled receptors, which do not trigger sphingomyelin hydrolysis.
Some pressing questions that immediately arise are concerned with the molecular mechanism of ceramide binding to and activation of c-Raf and the possibility that ceramide stimulation of c-Raf also signals to other MAPK modules like the stress-activated protein kinases (31) , as has recently been suggested for HL-60 cells (32) .
